The Egyptian government has enlisted British companies backed by the Department for International Trade to help the country reform its healthcare system.
Vodafone, the British telecom operation has won a major contract that will from a key-part of the Egyptian government’s push to roll out NHS-style universal healthcare for every man, woman and child in the country.
With backing from the Department for International Trade, Vodafone has secured a £100m project to build Egypt’s new Health Insurance IT system.
The government in Cairo want the IT to underpin a new primary healthcare system similar to that which operates in the UK.
Partnering Vodafone is IT giant DXC Technology, who are already responsible for the IT infrastructure services across the NHS Supply Chain.
It comes as UK firms and government work together to undertake a range of other healthcare activity, to share the benefits of the NHS and British pharmaceutical industry with Egypt.
- The NHS has trained 33 Egyptian GPs, with plans for a total of 300 doctors to be trained by 2020
- Department for International Trade and Healthcare UK have supported over £1.3 billion of NHS exports since 2016
- Glaxo Smith Kline (GSK) to boost local manufacturing hubs in Cairo to meet soaring local demand, creating 60 new jobs
Vodafone to help build universal healthcare IT platform
Vodafone’s programme in partnership with DXC is to provide a digital healthcare services platform to facilitate the roll-out of Egypt’s universal health insurance scheme.
It will begin as a pilot in Port Said, before being rolled out to four other governorates and then nationwide, potentially benefiting millions of ordinary Egyptians.
The NHS is also sharing its world-leading healthcare expertise with doctors and nurses from Egypt thanks to a healthcare Memorandum of Understanding (MOU) that offers training to medical professionals in Egypt. NHS practitioners have already trained the first group of 33 GPs in Egypt, with plans for a total of 300 doctors to be trained by 2020.
Secretary of State for International Trade Liam Fox said:
“We in Britain are proud of our NHS and how it provides access to healthcare for everyone. I myself used to be an NHS doctor before becoming an MP, so I know how important it is.”
“It is a system that is respected around the world and we want to help other countries do what they can to secure the same benefits for their people.”
“That’s why we’ve stood by Vodafone as it sought and secured this contract which, as part of the Egyptian government’s reforms, will help revolutionise healthcare for people here – It is the beginning of an Egyptian NHS for the Egyptian people.”
GSK invest in Cairo manufacturing plants
British pharmaceutical giant GSK Consumer Healthcare, a GlaxoSmithKline company has also invested around 100m Egyptian Pounds (EGP) in two major production lines in Cairo to meet local demand for its products.
GSK Consumer Healthcare aims to produce more Voltaren Emulgel (pain relief) and Otrivin (decongestant spray) through local manufacturing, creating 60 new jobs in Egypt. Demand for British medicines in Africa has soared by 78% over the last decade and pharmaceutical exports to the region are now worth £455.9m.
Egypt is already bearing the fruit of its cooperation with the UK as a new wave of British investors seek to do business in Egypt. To further enhance the strategic ties between the UK and African countries, the government is hosting an Africa Investment Summit on 20 January 2020 in London.